FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formula , wherein R1 represents methyl or ethyl, R2 represents hydrogen, fluorine or methyl, R3 represents hydrogen, fluorine or methyl, each R4 represents hydrogen and R5 represents hydrogen, methyl. The invention also refers to a pharmaceutical composition for treating or relieving a degree of severity of a proliferative disorder by means of compounds of formula (I).
EFFECT: compounds are effective in preparing a drug for treating or reducing a degree of severity of metastatic cancer, glioblastoma, gastric carcinoma or cancer specified in colon cancer, breast cancer, prostate cancer, cerebral cancer, liver cancer, pancreatic cancer or lung cancer and hepatocellular carcinoma.
16 cl, 4 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF SPIRO-[ISOQUINOLINE-4-(1H)-3-PYRROLIDINE]-1,2',3,5'-(2H)-TETR- -ONE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION USED FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS-RELATED COMPLICATIONS | 1991 |
|
RU2110518C1 |
AZALACTAM COMPOUNDS AS INHIBITORS OF HPK1 | 2021 |
|
RU2819642C1 |
1H-PYRAZOLO[3,4-B]PYRIDINES AND THEIR THERAPEUTIC APPLICATIONS | 2013 |
|
RU2689141C2 |
DERIVATIVES OF BENZISOXAZOLESULFONAMIDE | 2020 |
|
RU2813356C2 |
NEW PYRIMIDINE DERIVATIVE WITH AN EFFECT OF INHIBITING GROWTH OF CANCER CELLS AND PHARMACEUTICAL COMPOSITION CONTAINING IT | 2018 |
|
RU2744168C1 |
2,5-DISUBSTITUTED ARYLSULPHONAMIDE CCR3 ANTAGONISTS | 2010 |
|
RU2532515C2 |
PYRIDYLOXY DERIVATIVES EFFECTIVE AS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) GAMMA ACTIVATOR/MODULATOR | 2010 |
|
RU2480463C1 |
N- (PHENYLSULPHONYL) BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS | 2017 |
|
RU2744358C2 |
SUBSTITUTED INDOL-5-OL DERIVATIVES AND THERAPEUTIC APPLICATIONS THEREOF | 2013 |
|
RU2674249C2 |
SUBSTITUTED QUINOLINE COMPOUNDS AND METHODS OF THEIR APPLICATION | 2012 |
|
RU2568258C2 |
Authors
Dates
2015-06-10—Published
2010-05-27—Filed